Axsome Therapeutics, Inc. financial data

Symbol
AXSM on Nasdaq
Industry
Pharmaceutical Preparations
Location
One World Trade Center, 22 Nd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 332 % -6.46%
Quick Ratio 9.57 % +50.9%
Debt-to-equity 223 % +44.5%
Return On Equity -174 % -55.5%
Return On Assets -54.1 % -22.4%
Operating Margin -105 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48M shares +1.72%
Common Stock, Shares, Outstanding 47.8M shares +2.3%
Entity Public Float 2.8B USD +133%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 47.6M shares +8.94%
Weighted Average Number of Shares Outstanding, Diluted 47.6M shares +8.94%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 291M USD +86.7%
Cost of Revenue 1.9M USD
Research and Development Expense 146M USD +115%
General and Administrative Expense 81.1M USD +131%
Costs and Expenses 597M USD +67.6%
Operating Income (Loss) -306M USD -75.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -310M USD -69.6%
Income Tax Expense (Benefit) -1M USD
Net Income (Loss) Attributable to Parent -309M USD -67.3%
Earnings Per Share, Basic -6.58 USD/shares -53.7%
Earnings Per Share, Diluted -6.58 USD/shares -53.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 316M USD -27.8%
Accounts Receivable, after Allowance for Credit Loss, Current 120M USD +78.5%
Inventory, Net 15.2M USD +64.5%
Assets, Current 463M USD -10.9%
Property, Plant and Equipment, Net 724K USD -1.63%
Operating Lease, Right-of-Use Asset 6.07M USD -18.1%
Intangible Assets, Net (Excluding Goodwill) 50.1M USD -11.3%
Goodwill 12M USD 0%
Other Assets, Noncurrent 507K USD +59.9%
Assets 548M USD -10.4%
Accounts Payable, Current 61.3M USD +42.8%
Employee-related Liabilities, Current 16.2M USD +63.1%
Liabilities, Current 187M USD +62.3%
Operating Lease, Liability, Noncurrent 6.83M USD -9.43%
Liabilities 445M USD +33.8%
Retained Earnings (Accumulated Deficit) -983M USD -45.7%
Stockholders' Equity Attributable to Parent 103M USD -63.1%
Liabilities and Equity 548M USD -10.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.5M USD -819%
Net Cash Provided by (Used in) Financing Activities -1.19M USD -102%
Net Cash Provided by (Used in) Investing Activities -98K USD -38%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 47.8M shares +2.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -54.8M USD -220%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 316M USD -27.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.9M USD +52.5%
Deferred Tax Assets, Valuation Allowance 223M USD +21.2%
Deferred Tax Assets, Gross 225M USD +22%
Operating Lease, Liability 8.25M USD +4.54%
Depreciation 132K USD +46.7%
Payments to Acquire Property, Plant, and Equipment 98K USD +38%
Lessee, Operating Lease, Liability, to be Paid 10.9M USD -5.79%
Operating Lease, Liability, Current 1.42M USD +305%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.52M USD +2.81%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.98M USD +174%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.64M USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.52M USD 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.2M USD +27.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.39M USD +0.06%
Share-based Payment Arrangement, Expense 12.8M USD -55.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%